Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Sunday, November 1, 2026

Back to today

From X

@ParadisLabs 1 click

Paradis on X

Memory fundamentals are still very strong (stronger than Q1). $MU CEO: - "We expect memory and storage supply demand conditions to be much tighter in fiscal 2027 and 2028 than they were in 2026." - "We do not have line of sight to when supply and demand will return to balance." Back in July, $NVDA supply commitments rocketed from $119B -> $279B which was "primarily related to the procurement of memory", with ~$175B of commitments for 2028-29... $MU also said that >75% of FY27 output is already committed + "a majority of discussions with our customers today are already around 2028." So as a reminder....ultra long-term demand visibility in the context of the memory market. Samsung’s Q3 prelim last week was 107.4T Won O.P. on 195T Won revenue: - So that's ~55% margins company-wide. - Micron did 87% GM in their most recent quarter - $SNDK 84.6% GM. All accelerating/stabilizing margins as of their most recent fiscal Q's. Mass production from new capacity (from Micron, Samsung and SKHY) is also not expected to come online for quite some time. In other words, the shortage will intensify next year at least. Then long-term contracts solidify long-term earnings further via price floors + committed volumes: - $MU with 26 SCAs worth >35% of revenue through to 2030 with some now running into 2031. - $MU CFO: "even at floor prices, we expect margins meaningfully above any prior cycle peak margins." - $SKHY has ~10 LTAs of ~5 yrs w/ pricing structures "designed to respond to price fluctuations." - Sammy (as of recent reporting) holds ~70% of memory capacity under LTAs until 2031 with $MSFT, $NVDA and $GOOGL, with ~25% of contract value prepaid. - $SNDK also has their "New Business Model" agreements with 8 customers that lock in ~66% of fy28. Then on buybacks, $MU will step up returns from December - "over time, we expect to return 100% of our excess cash." Just crazy how much cash these companies are bathing in rn. Obviously there are risks, mainly with positioning and sentiment towards the AI trade currently - thanks to macro/ARR fears/pacing talks/other stuff I'm probably forgetting rn. China is ofc another risk with CXMT but I don't see how they'll be a massive problem for HBM / US hyperscaler RDIMM where they'll continue to face US restrictions + massive qualification walls imo. But ultimately, memory fundamentals are in-tact and very strong. Stronger than Q1.
@DOMOCAPITAL

DOMO Capital Management, LLC on X

Wow - @ryancohen was right. These are not the actions of a value investor. This is hardcore trading. Is there any recommendation @michaeljburry has actually held for longer than a month (or that has actually increased in value) since this newsletter has started??? $GME would have counted in both categories if he had actually held.... Just brutal performance since inception. Maybe this is why he has refused to publicly release his funds performance? I think Burry is the only "big name" investor where the public has no clue what the actual performance of the fund was since inception. Crazy lack of transparency.

Investor Letters

All letters

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 3 clicks

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $20B
Stock Thoughts 4 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B
Cestrian Capital Research 3 clicks
T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

T $144B
Value Investors Club

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B
Cestrian Capital Research 1 click

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $22B
WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 69 of 271

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.